Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP192822.RAXtm0jhjHB7fNKPqYEMeGlZL0Kgxtw70UI-65vyJUi2U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP192822.RAXtm0jhjHB7fNKPqYEMeGlZL0Kgxtw70UI-65vyJUi2U130_assertion type Assertion NP192822.RAXtm0jhjHB7fNKPqYEMeGlZL0Kgxtw70UI-65vyJUi2U130_head.
- NP192822.RAXtm0jhjHB7fNKPqYEMeGlZL0Kgxtw70UI-65vyJUi2U130_assertion description "[An effect of GSTM1 and GSTT1 double null genotype on lymphoma risk was also shown (OR 2.09, 95% CI 1.31, 3.33; p = 0.01; random-effects model).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP192822.RAXtm0jhjHB7fNKPqYEMeGlZL0Kgxtw70UI-65vyJUi2U130_provenance.
- NP192822.RAXtm0jhjHB7fNKPqYEMeGlZL0Kgxtw70UI-65vyJUi2U130_assertion evidence source_evidence_literature NP192822.RAXtm0jhjHB7fNKPqYEMeGlZL0Kgxtw70UI-65vyJUi2U130_provenance.
- NP192822.RAXtm0jhjHB7fNKPqYEMeGlZL0Kgxtw70UI-65vyJUi2U130_assertion SIO_000772 22734843 NP192822.RAXtm0jhjHB7fNKPqYEMeGlZL0Kgxtw70UI-65vyJUi2U130_provenance.
- NP192822.RAXtm0jhjHB7fNKPqYEMeGlZL0Kgxtw70UI-65vyJUi2U130_assertion wasDerivedFrom befree-20140225 NP192822.RAXtm0jhjHB7fNKPqYEMeGlZL0Kgxtw70UI-65vyJUi2U130_provenance.
- NP192822.RAXtm0jhjHB7fNKPqYEMeGlZL0Kgxtw70UI-65vyJUi2U130_assertion wasGeneratedBy ECO_0000203 NP192822.RAXtm0jhjHB7fNKPqYEMeGlZL0Kgxtw70UI-65vyJUi2U130_provenance.